NME2P1
Putative nucleoside diphosphate kinase
Also known as: NDK8_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for NME2P1 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
137 residues, UniProt reviewed canonical sequence.
>O60361|NME2P1
1 MQCGLVGKII KRFEQKGFRL VAMKFLPASE EHLKQHYIDL KDRPFFPGLV KYMNSGPVVA
61 MVWEGLNVVK TGRVMLGETN PADSKPGTIR GDFCIQVGRN IIHGSDSVKS AEKEISLRFK
121 PEELVDYKSC AHDWVYELocalizationUniProt · AlphaFold · HPA
Whether an antibody against NME2P1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NME2P1 as an antibody target. Whether an autoantibody or antibody against NME2P1 could matter depends on whether native NME2P1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NME2P1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NME2P1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...